Cargando…
Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
BACKGROUND/AIMS: Organ failure in patients with acute decompensation (AD) is a defining characteristic of acute-on-chronic liver failure (ACLF). However, the clinical features of AD during the long-term clinical course of hepatocellular carcinoma (HCC) are still poorly understood. This study aimed t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794202/ https://www.ncbi.nlm.nih.gov/pubmed/35085277 http://dx.doi.org/10.1371/journal.pone.0261619 |
_version_ | 1784640780853313536 |
---|---|
author | Kondo, Takayuki Koroki, Keisuke Kanzaki, Hiroaki Kobayashi, Kazufumi Kiyono, Soichiro Nakamura, Masato Kanogawa, Naoya Saito, Tomoko Ogasawara, Sadahisa Ooka, Yoshihiko Nakamoto, Shingo Chiba, Tetsuhiro Arai, Makoto Kato, Jun Kuboki, Satoshi Ohtsuka, Masayuki Kato, Naoya |
author_facet | Kondo, Takayuki Koroki, Keisuke Kanzaki, Hiroaki Kobayashi, Kazufumi Kiyono, Soichiro Nakamura, Masato Kanogawa, Naoya Saito, Tomoko Ogasawara, Sadahisa Ooka, Yoshihiko Nakamoto, Shingo Chiba, Tetsuhiro Arai, Makoto Kato, Jun Kuboki, Satoshi Ohtsuka, Masayuki Kato, Naoya |
author_sort | Kondo, Takayuki |
collection | PubMed |
description | BACKGROUND/AIMS: Organ failure in patients with acute decompensation (AD) is a defining characteristic of acute-on-chronic liver failure (ACLF). However, the clinical features of AD during the long-term clinical course of hepatocellular carcinoma (HCC) are still poorly understood. This study aimed to clarify features and impact of AD/ACLF on the prognosis of patients after treatment for HCC. METHODS: This retrospective study enrolled 556 consecutive patients who were initially diagnosed with HCC, and analyses were conducted taking into account HCC treatment type, HCC stage, and presence or absence of cirrhosis. RESULTS: During follow-up, 299 patients with AD were hospitalized. AD occurrence is closely related to prognosis, regardless of the presence or absence of cirrhosis and HCC stage, and early-onset AD (within 90 days after HCC treatment) has negative impact on prognosis. In the intermediate-advanced–stage group, surgical resection had a positive impact on AD incidence post-treatment. After systemic therapy for HCC, renal impairment was the predictive factors for AD development. The 28/90-day mortality rate was higher among 41 cases (13.7%) with AD who exhibited ACLF as compared with cases without ACLF. AD without cirrhosis had similar ACLF incidence and short-term mortality, compared to AD with cirrhosis. The prognostic model using a decision-tree–based approach, which includes ACLF, bilirubin level, HCC progression, and MELD score is useful for predicting 90- or 28-day mortality after AD diagnosis. CONCLUSIONS: Careful management of patients with HCC who are hospitalized with AD is necessary, considering ACLF, HCC progression, and liver function. |
format | Online Article Text |
id | pubmed-8794202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-87942022022-01-28 Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma Kondo, Takayuki Koroki, Keisuke Kanzaki, Hiroaki Kobayashi, Kazufumi Kiyono, Soichiro Nakamura, Masato Kanogawa, Naoya Saito, Tomoko Ogasawara, Sadahisa Ooka, Yoshihiko Nakamoto, Shingo Chiba, Tetsuhiro Arai, Makoto Kato, Jun Kuboki, Satoshi Ohtsuka, Masayuki Kato, Naoya PLoS One Research Article BACKGROUND/AIMS: Organ failure in patients with acute decompensation (AD) is a defining characteristic of acute-on-chronic liver failure (ACLF). However, the clinical features of AD during the long-term clinical course of hepatocellular carcinoma (HCC) are still poorly understood. This study aimed to clarify features and impact of AD/ACLF on the prognosis of patients after treatment for HCC. METHODS: This retrospective study enrolled 556 consecutive patients who were initially diagnosed with HCC, and analyses were conducted taking into account HCC treatment type, HCC stage, and presence or absence of cirrhosis. RESULTS: During follow-up, 299 patients with AD were hospitalized. AD occurrence is closely related to prognosis, regardless of the presence or absence of cirrhosis and HCC stage, and early-onset AD (within 90 days after HCC treatment) has negative impact on prognosis. In the intermediate-advanced–stage group, surgical resection had a positive impact on AD incidence post-treatment. After systemic therapy for HCC, renal impairment was the predictive factors for AD development. The 28/90-day mortality rate was higher among 41 cases (13.7%) with AD who exhibited ACLF as compared with cases without ACLF. AD without cirrhosis had similar ACLF incidence and short-term mortality, compared to AD with cirrhosis. The prognostic model using a decision-tree–based approach, which includes ACLF, bilirubin level, HCC progression, and MELD score is useful for predicting 90- or 28-day mortality after AD diagnosis. CONCLUSIONS: Careful management of patients with HCC who are hospitalized with AD is necessary, considering ACLF, HCC progression, and liver function. Public Library of Science 2022-01-27 /pmc/articles/PMC8794202/ /pubmed/35085277 http://dx.doi.org/10.1371/journal.pone.0261619 Text en © 2022 Kondo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kondo, Takayuki Koroki, Keisuke Kanzaki, Hiroaki Kobayashi, Kazufumi Kiyono, Soichiro Nakamura, Masato Kanogawa, Naoya Saito, Tomoko Ogasawara, Sadahisa Ooka, Yoshihiko Nakamoto, Shingo Chiba, Tetsuhiro Arai, Makoto Kato, Jun Kuboki, Satoshi Ohtsuka, Masayuki Kato, Naoya Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title | Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title_full | Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title_fullStr | Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title_full_unstemmed | Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title_short | Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
title_sort | impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794202/ https://www.ncbi.nlm.nih.gov/pubmed/35085277 http://dx.doi.org/10.1371/journal.pone.0261619 |
work_keys_str_mv | AT kondotakayuki impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT korokikeisuke impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT kanzakihiroaki impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT kobayashikazufumi impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT kiyonosoichiro impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT nakamuramasato impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT kanogawanaoya impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT saitotomoko impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT ogasawarasadahisa impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT ookayoshihiko impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT nakamotoshingo impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT chibatetsuhiro impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT araimakoto impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT katojun impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT kubokisatoshi impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT ohtsukamasayuki impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma AT katonaoya impactofacutedecompensationontheprognosisofpatientswithhepatocellularcarcinoma |